ARTICLE | Company News
ProQuest Pharmaceuticals, Inc. other research news
October 1, 2001 7:00 AM UTC
ProQuest received a $100,000 Phase I SBIR grant from the National Heart, Lung, and Blood Institute to research the bioavailability and bioconversion of 4 oral cyclic RGD peptidomimetics, which have an...